Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Peak Bio Inc (PKBO)

Peak Bio Inc (PKBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Peak Bio Inc 4900 HOPYARD ROAD SUITE 100 PLEASANTON CA 94588 USA

https://peak-bio.com Employees: 21 P: 925-463-4800

Description:

Peak Bio Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing therapeutics addressing significant unmet needs in the areas of oncology and inflammation. The company's lead product candidate includes PHP-303. Peak Bio Co., Ltd., formerly known as Ignyte Acquisition Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 1,619
Enterprise Value, $K 2,139
Shares Outstanding, K 23,125
Annual Sales, $ 370 K
Annual Net Income, $ -12,830 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,430 K
EBIT, $ -8,050 K
EBITDA, $ -7,740 K
60-Month Beta 1.56
% of Insider Shareholders 19.90%
% of Institutional Shareholders 0.00%
Float, K 18,523
% Float 80.10%
Short Volume Ratio 0.98

Growth:

1-Year Return -39.13%
3-Year Return -99.28%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.09 on 08/23/24
Next Earnings Date N/A
Earnings Per Share ttm -0.41
EPS Growth vs. Prev Qtr 18.18%
EPS Growth vs. Prev Year 68.97%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PKBO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -253.92%
Profit Margin % -3,467.57%
Debt/Equity -0.08
Price/Sales 3.14
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.91
Interest Coverage -3.70
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar